The device was not returned for evaluation as it was implanted in the patient.The device was not returned for analysis; therefore, the complaint of migration after deployment issue could not be confirmed, and the event cause could not be determined.It is possible that the reported mass effect of the partially thrombosed aneurysm induced parent vessel stenosis; this remodeling of the vessel caused the initial device to inadequately cover the aneurysm neck.Per our instructions for use (ifu): a thrombosed aneurysm may aggravate pre-existing, or cause new, symptoms of mass effect and may require medical therapy.Do not use in patients in whom the angiography demonstrates the anatomy is not appropriate for endovascular treatment, due to conditions such as severe intracranial vessel tortuosity or stenosis.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
Citation: ¿effect of antiplatelet therapy on thromboembolism after flow diversion with the pipeline embolization device¿ robert s.Heller, m.D., venkata dandamudi, m.D., michael lanfranchi, m.D., and adel m.Malek, m.D., ph.D.Medtronic received report that 23 patients with 26 intracranial aneurysms received a ped for treatment of their aneurysms.The mean age of 55.6 years (range 17¿77 years) and consisted of 5 men and 19 women.A single aneurysm required repeat treatment following the initial flow diverter embolization.Mass effect of the partially thrombosed aneurysm induced parent vessel stenosis; which remodel the vessel caused the initial flow diverter to inadequately cover the aneurysm neck, requiring deployment of a second device.
|